Table 1. Characterization of the participants with DM2 according to the clinical variables. Picos, PI, Brazil, 2018.

Variables	Total (n=103)	Control Group (n=56)	Experimental Group (n=47)	p
Time with diabetes				0.670*
2-5 years	42 (40.8%)	22 (39.3%)	20 (42.6%)
5-10 years	33 (32.0%)	20 (35.7%)	13 (27.7%)
> 10 years	28 (27.2%)	14 (25.0%)	14 (29.8%)
Hypertension				0.274*
Yes	62 (60.2%)	31 (55.4%)	31 (66%)
No	41 (39.8%)	25 (44.6%)	16 (34%)
Follow-up in the PHCU				0.558*
Monthly	18 (17.5%)	09 (16.1%)	09 (19.1%)
Quarterly	45 (43.7%)	28 (50.0%)	17 (36.2%)
Semiannual	26 (25.2%)	12 (21.4%)	14 (29.8%)
Others	14 (13.6%)	07 (12.5%)	07 (14.9%)
Physical Activity
Before the Intervention	38 (35.9%)	21 (37.5%)	17 (36.2%)	0.889*
After the Intervention	35 (34.0%)	19 (33.9%)	16 (34.0%)	0.990*
Hypoglycemia in the last 30 days				0.623*
Yes	04 (3.9%)	03 (5.4%)	01 (2.1%)
No	99 (96.1%)	53 (94.6%)	46 (97.9%)
Hyperglycemia in the last 30 days				0.081†
Yes	13 (12.6%)	04 (7.1%)	09 (19.1%)
No	90 (87.4%)	52 (92.9%)	38 (80.9%)
Systolic blood pressure		0.527‡	0.870‡
Before the Intervention	128.27±17.96	125.02±15.93	131.53±19.99	0.146§
After the Intervention	128.04±16.52	125.32±14.36	130.77±18.69	0.147§
Diastolic blood pressure		0.955‡	0.066‡
Before the Intervention	78.78±9.18	77.09±8.90	80.47±9.47	0.039§
After the Intervention	76.59±12.10	76.34±9.44	76.85±14.77	0.937§

^*Chi-square test;

^†Fisher's exact test;

^‡Wilcoxon's test;

^§Mann-Whitney's test. 95% confidence interval